secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-322859
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma regains Nasdaq minimum bid price compliance after prior deficiency
--------------------------------------------------------------------------------

- Received Nasdaq notice on Dec 17, 2025 confirming compliance with Listing Rule 5450(a)(1) after 10 consecutive business days with closing bid at or above $1.00.
- Non-compliance was initially disclosed on June 20, 2025 when bid price fell below $1.00 for 30 consecutive business days.
- Listing matter is now closed; company meets all other Nasdaq Global Market continued listing criteria.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000119312525322859/0001193125-25-322859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000119312525322859/d40412d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-322859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer